Diabetes drug shows success for heart failure patients: Manitoba study
A drug initially meant for treating diabetes is proving to be effective in helping heart failure patients lead longer and healthier lives, according to a recently published study from a Manitoba doctor.
St. Boniface Hospital cardiologist Dr. Shelley Zieroth enrolled patients in a phase three clinical trial called The Emperor-Preserved Trial which looked at the drug called Empagliflozin.
“It’s really quite a remarkable journey for this class of drugs,” Zieroth said. “Empagliflozin is known as an SGLT2 inhibitor which was originally tested in and proven to be beneficial as a blood glucose-lowering agent in individuals with type 2 diabetes.”
What this study did was test the drug in heart failure patients with preserved injection fraction. Dr. Zieroth described this as a type of heart failure where the pumping function of the heart is fine but the heart itself is very stiff.
“Until now, there really has been no effective therapies to improve long-term outcomes,” she said.
The findings from this study show that Empagliflozin resulted in a 21 per cent relative risk reduction in cardiovascular death or hospitalization for heart failure. Dr. Zieroth called this trial a landmark for both clinicians and patients.
“We know hospitalization for heart failure is a significant burden on the health-care system,” Zieroth said. “In fact, in patients over 65, it’s one of the top three causes of hospitalization.”
She said hospitalizations are where most of the money is spent on heart failure care, not the medications.
“Anything we can do to reduce heart failure hospitalizations thus has a positive impact on the health care system but also improves patient outcomes.”
The next step is to apply to Health Canada for rapid approval of this drug for this patient group.
CTVNews.ca Top Stories
Expert warns of food consumption habits amid rising prices
A new survey by Dalhousie University's Agri-Food Analytics Lab asked Canadians about their food consumption habits amid rising prices.
Documents reveal Ottawa's efforts to get Loblaw, Walmart on board with grocery code
It was evident to the federal government as early as last fall that Loblaw and Walmart might be holdouts to the grocery code of conduct, jeopardizing the project's success.
opinion The special relationship between King Charles and the Princess of Wales
Royal commentator Afua Hagan writes that when King Charles recently admitted Catherine to the Order of the Companions of Honour, it not only made history, but it reinforced the strong bond between the King and his beloved daughter-in-law.
Charlie Woods, son of Tiger, shoots 81 in U.S. Open qualifier
Charlie Woods failed to advance in a U.S. Open local qualifying event Thursday, shooting a 9-over 81 at Legacy Golf & Tennis Club.
Improve balance and build core strength with this exercise
When it comes to cardiovascular fitness, you may tend to focus on activities that move you forward, such as walking, running and cycling.
New Norad commander calls Canada's defence policy update 'very encouraging'
American troops will be spending more time training in the Far North, the new commander of Norad says, a strategy that fits 'hand-in-glove' with Canada's renewed focus on Arctic defence.
B.C. tenants evicted for landlord's use after refusing large rent increase to take over neighbouring suite
Ashley Dickey and her mother rented part of the same Coquitlam duplex in three different decades under three different landlords.
Mountain guide dies after falling into a crevasse in Banff National Park
A man who fell into a crevasse while leading a backcountry ski group deep in the Canadian Rockies has died.
$70M Lotto Max winners kept prize a secret from family for 2 months
During a special winner celebration near their hometown, Doug and Enid shared the story of how they discovered they were holding a Lotto Max ticket worth $70 million and how they kept this huge secret for so long.